The Four Critical Priority Fungi According to the World Health Organization and the Hope for New Therapies: A Focus on Cell Wall Antifungal Targets. [PDF]
Marena GD +6 more
europepmc +1 more source
New WHO Blueprint and Digital Platform Look to Strengthen Surveillance of Fungal Disease and Antifungal Resistance. [PDF]
Novak S.
europepmc +1 more source
Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children. [PDF]
Colombo AL +7 more
europepmc +1 more source
Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report
Mori, Giovanni +4 more
openaire +3 more sources
<i>Candida parapsilosis</i> and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? [PDF]
Vahedi-Shahandashti R +2 more
europepmc +1 more source
Real-world clinical experience with rezafungin: a case series from a UK tertiary care centre
Irfana Pharveen +4 more
doaj +1 more source
The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us. [PDF]
Lowe A, King ST, Hand J.
europepmc +1 more source
Successful rezafungin treatment of an azole-resistant Candida parapsilosis vascular graft infection. [PDF]
Benítez-Cano A +7 more
europepmc +1 more source
Antifungal activity of rezafungin in invasive candidiasis: From bench to bed
Guillermo Quindós +3 more
openaire +1 more source
Activity of Rezafungin Against Echinocandin Non-wild type <i>Candida glabrata</i> Clinical Isolates From a Global Surveillance Program. [PDF]
Castanheira M +3 more
europepmc +1 more source

